MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6405-1210-1216$20.00
Mol Pharmacol 64:1210-1216, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bodor, E. T.
Right arrow Articles by Harden, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bodor, E. T.
Right arrow Articles by Harden, T. K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Purification and Functional Reconstitution of the Human P2Y12 Receptor

Erik T. Bodor, Gary L. Waldo, Shelley B. Hooks, James Corbitt, Jose L. Boyer , and T. Kendall Harden

Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina

The human P2Y12 receptor (P2Y12-R) is a member of the G protein coupled P2Y receptor family, which is intimately involved in platelet physiology. We describe here the purification and functional characterization of recombinant P2Y12-R after high-level expression from a baculovirus in Sf9 insect cells. Purified P2Y12-R, G{beta}1{gamma}2, and various G{alpha}-subunits were reconstituted in lipid vesicles, and steady-state GTPase activity was quantified. GTP hydrolysis in proteoliposomes formed with purified P2Y12-R and G{alpha}i2{beta}1{gamma}2 was stimulated by addition of either 2-methylthio-ADP (2MeSADP) or RGS4 and was markedly enhanced by their combined presence. 2MeSADP was the most potent agonist (EC50 = 80 nM) examined, whereas ADP, the cognate agonist of the P2Y12-R, was 3 orders of magnitude less potent. ATP had no effect alone but inhibited the action of 2MeSADP; therefore, ATP is a relatively low-affinity antagonist of the P2Y12-R. The G protein selectivity of the P2Y12-R was examined by reconstitution with various G protein {alpha}-subunits in heterotrimeric form with G{beta}1{gamma}2. The most robust coupling of the P2Y12-R was to G{alpha}i2, but effective coupling also occurred to G{alpha}i1 and G{alpha}i3. In contrast, little or no coupling occurred to G{alpha}o or G{alpha}q. These results illustrate that the signaling properties of the P2Y12-R can be studied as a purified protein under conditions that circumvent the complications that occur in vivo because of nucleotide metabolism and interconversion as well as nucleotide release.


Received July 15, 2003; accepted August 13, 2003.

Address correspondence to: Dr. T. Kendall Harden, Department of Pharmacology, CB#7365, University of North Carolina Chapel Hill, Chapel Hill, NC 27599-7365. E-mail: tkh{at}med.unc.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. I. Masyuk, S. A. Gradilone, J. M. Banales, B. Q. Huang, T. V. Masyuk, S.-O. Lee, P. L. Splinter, A. J. Stroope, and N. F. LaRusso
Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors
Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G725 - G734.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
I. P. Fricks, S. Maddileti, R. L. Carter, E. R. Lazarowski, R. A. Nicholas, K. A. Jacobson, and T. K. Harden
UDP Is a Competitive Antagonist at the Human P2Y14 Receptor
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 588 - 594.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. J. Rayment, V. Ralevic, D. A. Barrett, R. Cordell, and S. P. H. Alexander
A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release
FASEB J, February 1, 2007; 21(2): 577 - 585.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al.
International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy
Pharmacol. Rev., September 1, 2006; 58(3): 281 - 341.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Reigada, W. Lu, X. Zhang, C. Friedman, K. Pendrak, A. McGlinn, R. A. Stone, A. M. Laties, and C. H. Mitchell
Degradation of extracellular ATP by the retinal pigment epithelium
Am J Physiol Cell Physiol, September 1, 2005; 289(3): C617 - C624.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. R. Hardy, P. B. Conley, J. Luo, J. L. Benovic, A. W. Poole, and S. J. Mundell
P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms
Blood, May 1, 2005; 105(9): 3552 - 3560.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. J. Zwartz, A. Chigaev, D. C. Dwyer, T. D. Foutz, B. S. Edwards, and L. A. Sklar
Real-time Analysis of Very Late Antigen-4 Affinity Modulation by Shear
J. Biol. Chem., September 10, 2004; 279(37): 38277 - 38286.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. J. Ennion, A. D. Powell, and E. P. Seward
Identification of the P2Y12 Receptor in Nucleotide Inhibition of Exocytosis from Bovine Chromaffin Cells
Mol. Pharmacol., September 1, 2004; 66(3): 601 - 611.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. L. Waldo and T. K. Harden
Agonist Binding and Gq-Stimulating Activities of the Purified Human P2Y1 Receptor
Mol. Pharmacol., February 1, 2004; 65(2): 426 - 436.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics